Coeptis Therapeutics Inc.

NASDAQ: COEP · Real-Time Price · USD
13.96
2.48 (21.60%)
At close: Aug 15, 2025, 3:59 PM
13.81
-1.11%
After-hours: Aug 15, 2025, 06:35 PM EDT

Coeptis Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.08 -18.94 -11.65 -15.2
PEG Ratio
-0.00 0.27 0.15 -0.01
PS Ratio
n/a n/a n/a 2.73K
PB Ratio
3.32 494.89 91.16 86.96
P/FCF Ratio
-1.59 -55.64 -112.98 -32.76
P/OCF Ratio
-1.59 -55.64 -112.98 -45.53
OCF/S Ratio
n/a n/a n/a -59.86
Debt / Equity Ratio
0.44 1.50 0.36 1.74
Quick Ratio
0.23 0.59 2.16 0.79
Current Ratio
0.23 0.59 2.16 0.79
Asset Turnover
n/a n/a n/a 0.01
Interest Coverage
n/a 198.99 -156.57 -75.06
Return on Equity
-3.08 -26.13 -7.82 -5.72
Return on Assets
-1.1 -4.65 -4.75 -1.99
Return on Invested Capital
-1.61 -8.28 -4.48 -2.18
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a -4.96
Net Profit Margin
n/a n/a n/a -179.32
Pretax Profit Margin
n/a n/a n/a -179.32
Operating Profit Margin
n/a n/a n/a -187.28
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a -170.87